Connection

PABLO C OKHUYSEN to Female

This is a "connection" page, showing publications PABLO C OKHUYSEN has written about Female.
Connection Strength

0.253
  1. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagn Microbiol Infect Dis. 2017 Nov; 89(3):235-240.
    View in: PubMed
    Score: 0.017
  2. Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center: a 10-year retrospective study. Infect Dis (Lond). 2017 Feb; 49(2):113-119.
    View in: PubMed
    Score: 0.016
  3. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis. 2011 Jun; 52(11):1332-41.
    View in: PubMed
    Score: 0.011
  4. Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea. Clin Vaccine Immunol. 2010 May; 17(5):879-81.
    View in: PubMed
    Score: 0.010
  5. A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. J Infect Dis. 2009 Feb 15; 199(4):477-85.
    View in: PubMed
    Score: 0.010
  6. Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol. 2008 Aug; 15(8):1194-8.
    View in: PubMed
    Score: 0.009
  7. PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol. 2008 Jul; 46(7):2227-30.
    View in: PubMed
    Score: 0.009
  8. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med. 2008 May-Jun; 15(3):156-61.
    View in: PubMed
    Score: 0.009
  9. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis. 2007 Apr 01; 44(7):945-52.
    View in: PubMed
    Score: 0.008
  10. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy. 2005 Oct; 25(10):1303-9.
    View in: PubMed
    Score: 0.008
  11. Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects. AIDS. 2005 Aug 12; 19(12):1333-4.
    View in: PubMed
    Score: 0.008
  12. Cryptosporidiosis in children. Semin Pediatr Infect Dis. 2004 Oct; 15(4):253-9.
    View in: PubMed
    Score: 0.007
  13. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004 Sep; 99(9):1774-8.
    View in: PubMed
    Score: 0.007
  14. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023 11 13; 41(11):1945-1962.e11.
    View in: PubMed
    Score: 0.007
  15. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep. 2002 Oct; 4(5):392-8.
    View in: PubMed
    Score: 0.006
  16. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer. 2022 Sep 01; 22(1):945.
    View in: PubMed
    Score: 0.006
  17. Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. J Infect Dis. 2002 May 01; 185(9):1320-5.
    View in: PubMed
    Score: 0.006
  18. Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections. Am J Clin Oncol. 2021 08 01; 44(8):402-408.
    View in: PubMed
    Score: 0.006
  19. Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum. 2020 03; 63(3):381-388.
    View in: PubMed
    Score: 0.005
  20. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):163-171.
    View in: PubMed
    Score: 0.005
  21. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer. BMC Cancer. 2019 Dec 18; 19(1):1233.
    View in: PubMed
    Score: 0.005
  22. Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy. Am J Clin Oncol. 2019 10; 42(10):789-796.
    View in: PubMed
    Score: 0.005
  23. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis. J Immunother Cancer. 2019 09 05; 7(1):242.
    View in: PubMed
    Score: 0.005
  24. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. Eur J Gastroenterol Hepatol. 2019 01; 31(1):128-134.
    View in: PubMed
    Score: 0.005
  25. Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection. Infect Immun. 2016 08; 84(8):2299-306.
    View in: PubMed
    Score: 0.004
  26. Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial. Clin Infect Dis. 1995 Aug; 21(2):341-4.
    View in: PubMed
    Score: 0.004
  27. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med. 2014 May-Jun; 21(3):153-8.
    View in: PubMed
    Score: 0.003
  28. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.003
  29. Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals? Clin Gastroenterol Hepatol. 2014 Jun; 12(6):1051-4.e1.
    View in: PubMed
    Score: 0.003
  30. St. Louis encephalitis in patients with human immunodeficiency virus infection. Clin Infect Dis. 1993 Jul; 17(1):140-1.
    View in: PubMed
    Score: 0.003
  31. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011 Sep; 53(6):523-31.
    View in: PubMed
    Score: 0.003
  32. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS. 2011 Jun 01; 25(9):1207-17.
    View in: PubMed
    Score: 0.003
  33. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med. 2011 Mar-Apr; 18(2):121-5.
    View in: PubMed
    Score: 0.003
  34. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med. 2011 Jan-Feb; 18(1):56-8.
    View in: PubMed
    Score: 0.003
  35. Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis. 2010 Jul 15; 51(2):123-30.
    View in: PubMed
    Score: 0.003
  36. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010 May; 48(5):1673-6.
    View in: PubMed
    Score: 0.003
  37. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010 Mar-Apr; 17(2):111-7.
    View in: PubMed
    Score: 0.003
  38. A comparative study of furazolidone and placebo in addition to oral rehydration in the treatment of acute infantile diarrhea. Scand J Gastroenterol Suppl. 1989; 169:39-46.
    View in: PubMed
    Score: 0.002
  39. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection. AIDS Res Hum Retroviruses. 2007 Dec; 23(12):1541-54.
    View in: PubMed
    Score: 0.002
  40. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med. 2007 Sep-Oct; 14(5):312-9.
    View in: PubMed
    Score: 0.002
  41. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):451-6.
    View in: PubMed
    Score: 0.002
  42. Rifaximin treatment of pathogen-negative travelers' diarrhea. J Travel Med. 2007 Jan-Feb; 14(1):16-9.
    View in: PubMed
    Score: 0.002
  43. High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun. 2007 Jan; 75(1):481-7.
    View in: PubMed
    Score: 0.002
  44. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006 May; 101(5):1112-6.
    View in: PubMed
    Score: 0.002
  45. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol. 2005 Dec; 43(12):6126-9.
    View in: PubMed
    Score: 0.002
  46. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis. 2003 Jul 15; 188(2):290-6.
    View in: PubMed
    Score: 0.002
  47. In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies. J Eukaryot Microbiol. 2001; Suppl:95S-98S.
    View in: PubMed
    Score: 0.001
  48. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg. 1999 Jan; 60(1):157-64.
    View in: PubMed
    Score: 0.001
  49. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med. 1995 Mar 30; 332(13):855-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.